{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:03:34Z","timestamp":1761807814994},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1097\/rlu.0b013e318292ee9c","type":"journal-article","created":{"date-parts":[[2013,5,2]],"date-time":"2013-05-02T17:17:31Z","timestamp":1367515051000},"page":"560-563","source":"Crossref","is-referenced-by-count":16,"title":["18F-Fluorothymidine PET Is a Potential Predictive Imaging Biomarker of the Response to Gemcitabine-Based Chemotherapeutic Treatment for Recurrent Ovarian Cancer"],"prefix":"10.1097","volume":"38","author":[{"given":"Hideaki","family":"Tsuyoshi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumiko","family":"Morishita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Orisaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidehiko","family":"Okazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-16-20210204","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1158\/1078-0432.CCR-06-3025","article-title":"Early response assessment using 3-deoxy-3-18Ffluorothymidine-positron emission tomography in high-grade non-Hodgkins lymphoma.","volume":"13","author":"Herrmann","year":"2007","journal-title":"Clin Cancer Res"},{"key":"R2-16-20210204","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1200\/JCO.2006.10.5825","article-title":"Predicting treatment response of malignant gliomas to bevacizumab and irinotecan by imaging proliferation with 18F fluorothymidine positron emission tomography: a pilot study.","volume":"25","author":"Chen","year":"2007","journal-title":"J Clin Oncol"},{"key":"R3-16-20210204","doi-asserted-by":"crossref","first-page":"7423","DOI":"10.1158\/1078-0432.CCR-08-0312","article-title":"18FFluorothymidine positron emission tomography before and 7 days after gefitinib treatment predicts response in patients with advanced adenocarcinoma of the lung.","volume":"14","author":"Sohn","year":"2008","journal-title":"Clin Cancer Res"},{"key":"R4-16-20210204","doi-asserted-by":"crossref","first-page":"7664","DOI":"10.1158\/1078-0432.CCR-11-0783","article-title":"18F-3Deoxy-3-fluorothymidine positron emission tomography and breast cancer response to docetaxel.","volume":"17","author":"Contractor","year":"2011","journal-title":"Clin Cancer Res"},{"key":"R5-16-20210204","doi-asserted-by":"crossref","first-page":"866","DOI":"10.2967\/jnumed.109.069310","article-title":"18F-FLT PETCT for early response monitoring and dose escalation in oropharyngeal tumors.","volume":"51","author":"Troost","year":"2010","journal-title":"J Nucl Med"},{"key":"R6-16-20210204","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.nucmedbio.2010.12.003","article-title":"Noninvasive assessment of cell proliferation in ovarian cancer using 18F3deoxy-3-fluorothymidine positron emission tomographycomputed tomography imaging.","volume":"38","author":"Richard","year":"2011","journal-title":"Nucl Med Biol"},{"key":"R7-16-20210204","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s11307-012-0554-2","article-title":"Evaluation of 2-deoxy-2-(18)Ffluoro-D-glucose- and 3-deoxy-3-(18)Ffluorothymidine-positron emission tomography as biomarkers of therapy response in platinum-resistant ovarian cancer.","volume":"14","author":"Perumal","year":"2012","journal-title":"Mol Imaging Biol"},{"key":"R8-16-20210204","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.2967\/jnumed.109.073288","article-title":"18F-FLT PET as a surrogate marker of drug efficacy during mTOR inhibition by everolimus in a preclinical cisplatin-resistant ovarian tumor model.","volume":"51","author":"Aide","year":"2010","journal-title":"J Nucl Med"},{"key":"R9-16-20210204","doi-asserted-by":"crossref","first-page":"e12965","DOI":"10.1371\/journal.pone.0012965","article-title":"Early detection of response to experimental chemotherapeutic Top216 with 18FFLT and 18FFDG PET in human ovary cancer xenografts in mice.","volume":"5","author":"Jensen","year":"2010","journal-title":"PLoS One"},{"key":"R10-16-20210204","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1200\/JCO.2006.09.6735","article-title":"Randomized phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer.","volume":"25","author":"Mutch","year":"2007","journal-title":"J Clin Oncol"},{"key":"R11-16-20210204","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0090-8258(03)00011-8","article-title":"Phase II study of gemcitabine in recurrent platinum- and paclitaxel-resistant ovarian cancer.","volume":"88","author":"DAgostino","year":"2003","journal-title":"Gynecol Oncol"},{"key":"R12-16-20210204","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1200\/JCO.2007.13.6606","article-title":"Phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in progressive or recurrent ovarian cancer.","volume":"26","author":"Ferrandina","year":"2008","journal-title":"J Clin Oncol"},{"key":"R13-16-20210204","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.bcp.2009.09.025","article-title":"Predicting gemcitabine transport and toxicity in human pancreatic cancer cell lines with the positron emission tomography tracer 3-deoxy-3-fluorothymidine.","volume":"79","author":"Paproski","year":"2010","journal-title":"Biochem Pharmacol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0b013e318292ee9c","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T19:30:30Z","timestamp":1621884630000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201307000-00016"}},"subtitle":["Preliminary Results in Three Patients"],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":13,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0b013e318292ee9c","relation":{},"ISSN":["0363-9762"],"issn-type":[{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}